Sopharma Group
Accessible treatments for millions of people.
Our heritage
Contributing to the history of healthcare in Bulgaria.
As part of the national economic system we have closely followed the developments and turnarounds of our country, pursuing as a human mission high standards of quality, safety and efficiency of medication and spreading health culture while enhancing sector performances and achievements.
Looking ahead
Becoming a strong regional player and the first partnering choice.
A solid and long-lasting financial strategy based on profitability sustainable development and on strong performance in key markets. We are building a business strategy focused on diversification and expansion, in order to become the best and most attractive investment choice for our stakeholders.
Facts and News
Financial News
20 September 2018

Financial highlights

1,017,105
BGN '000 Revenues 2017
85,944
BGN '000 EBITDA 2017

Stock performance

Bulgarian Stock Exchange
Warsaw Stock Exchange

Stories

Creating a clear message and making a long story short.
The state-of-the-art solid dosage forms manufacturing facility of Sopharma AD in Sofia.